Shots: Foghorn will receive an upfront, development, regulatory and commercial milestones totaling up to $425M as well as royalties on sales of any approved therapy emerges from the collaboration Merck […]readmore
Tags : $425M
Shots: Pfizer is planning to pay $120M upfront along with $305M milestone payment BioNTech will also receive double-digit royalties post sales whereas, Pfizer acquires small stakes in BioNTech as part […]readmore